Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Anne M. Connolly, MD
Division of Neurology
Nationwide Children’s Hospital
700 Childrens Drive
Columbus, Ohio, United States
Anne M. Connolly, MD, is the Chief of the Division of Neurology at Nationwide Children’s Hospital, Professor of Pediatrics at The Ohio State University College of Medicine, and a Member of the Center for Gene Therapy in the Abigail Wexner Research Institute. She is an Internationally recognized expert in Pediatric Neuromuscular Disease and Neuroimmunology. Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, Dr. Connolly leads the Spinal Muscular Atrophy Clinic.
Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is an Associate Editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and Member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
A Dallas Startup Aims to Build a Big Business—and Transform Lives—by Curing Rare DiseasesBabies born with spinal muscular atrophy...
Connie Wolford, MSN, FNP-BCConnie Wolford, MSN, FNP-BC is an advanc...
Gene Therapy Improves Muscle Function for Children With Spinal Muscular AtrophyChildren with spinal muscular atrophy (S...
Brian G. Smith, MD, FAAP, FAOADr. Smith became the Chief of the Divisi...
Gene Replacement Therapy With Onasemnogene Abeparvovec in Children With Spinal Muscular Atrophy Aged 24 Months or Yo...Given the novelty of gene replacement th...
CHOP – Spinal Muscular Atrophy (SMA)Why Choose CHOP for SMA Treatment?Being ...
Lee Rubin, PhDLee Rubin investigates the key molecular...